Page last updated: 2024-08-25

5-hydroxymethylcytosine and fulvestrant

5-hydroxymethylcytosine has been researched along with fulvestrant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Balasubramanian, S; Broome, R; Carroll, JS; Chernukhin, I; D'Santos, C; Farcas, AM; Groen, AJ; Jamieson, S; Kishore, K; Mahtey, A; Mao, SQ; Papachristou, EK; Siersbæk, R; Tejedo, CG; Theodorou, V	1

Other Studies

1 other study(ies) available for 5-hydroxymethylcytosine and fulvestrant

Article	Year
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions. Cell reports, 2021, 02-23, Volume: 34, Issue:8 Topics: 5-Methylcytosine; Animals; Breast Neoplasms; Chromatin Assembly and Disassembly; Databases, Genetic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Enhancer Elements, Genetic; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Xenograft Model Antitumor Assays	2021

Article

Year

TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.

Cell reports, 2021, 02-23, Volume: 34, Issue:8

Topics: 5-Methylcytosine; Animals; Breast Neoplasms; Chromatin Assembly and Disassembly; Databases, Genetic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Enhancer Elements, Genetic; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Xenograft Model Antitumor Assays

2021